Y học mẹ và thai nhi

Optimizing Carrier Screening: Insights and Recommendations From a Maternal-Fetal Medicine Practice

By MedXY 10/06/2026

Carrier screening timing and protocols vary widely, often delaying risk assessment and increasing patient distress. Early or prepregnancy screening with concurrent partner testing and thorough counseling improves reproductive decision-making and equity in detecting genetic risks.

Clinical Updates news

Maternal-Fetal Alloimmunity and Gestational Outcomes: Assessing Anti-HLA Antibodies as a Risk Factor for Fetal Growth Restriction

By MedXY 06/01/2026

This review explores the association between maternal anti-HLA antibodies and fetal growth restriction (FGR), synthesizing evidence that suggests an alloimmune mechanism may contribute to placental dysfunction and restricted fetal development in a subset of unexplained cases.

news

Clinical Trajectory of Early-Onset Severe Fetal Growth Restriction: Insights into Umbilical Artery Doppler Progression and Management

By MedXY 03/30/2026

This report examines the progression of Umbilical Artery Doppler abnormalities in 241 severe early-onset FGR cases, providing critical timelines for clinical deterioration, delivery planning, and fetal death risk assessment.